RBC Europe’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$66K Hold
624
﹤0.01% 300
2022
Q1
$80K Sell
624
-19
-3% -$2.29K ﹤0.01% 305
2021
Q4
$79K Sell
643
-165
-20% -$21.6K ﹤0.01% 310
2021
Q3
$115K Sell
808
-226
-22% -$33.2K ﹤0.01% 387
2021
Q2
$161K Hold
1,034
0.01% 344
2021
Q1
$161K Hold
1,034
0.01% 320
2020
Q4
$155K Hold
1,034
0.01% 320
2020
Q3
$137K Hold
1,034
0.01% 310
2020
Q2
$120K Hold
1,034
0.01% 300
2020
Q1
$101K Sell
1,034
-165
-14% -$21.6K 0.01% 292
2019
Q4
$174K Hold
1,199
0.02% 265
2019
Q3
$160K Hold
1,199
0.02% 269
2019
Q2
$137K Hold
1,199
0.01% 296
2019
Q1
$149K Buy
1,199
+227
+23% +$25.8K 0.02% 275
2018
Q4
$97.9K Hold
972
0.01% 311
2018
Q3
$124K Hold
972
0.01% 319
2018
Q2
$105K Hold
972
0.01% 346
2018
Q1
$103K Hold
972
0.01% 336
2017
Q4
$114K Hold
972
0.01% 332
2017
Q3
$111K Buy
+972
New +$112K 0.01% 339

Other funds holding ZBH

RBC Europe's ZBH Position: Q2 2022 in Review

RBC Europe held its Zimmer Biomet (ZBH) position steady in Q2 2022 at 624 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #300.

RBC Europe first reported a position in ZBH in Q3 2017 and has held it in 20 quarters since. The position peaked at $174K in Q4 2019. 957 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • RBC Europe held 624 shares of Zimmer Biomet worth $66K as of Q2 2022.
  • RBC Europe left its Zimmer Biomet share count unchanged in Q2 2022.
  • Zimmer Biomet made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #300 holding.
  • RBC Europe first reported a position in Zimmer Biomet in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Zimmer Biomet position peaked at $174K in Q4 2019.
  • 957 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.